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Abstract
Background: Randomised trials evaluation of surgical interventions are often designed and analysed as if the
outcome of individual patients is independent of the surgeon providing the intervention. There is reason to expect
outcomes for patients treated by the same surgeon tend to be more similar than those under the care of another
surgeon due to previous experience, individual practice, training, and infrastructure. Such a phenomenon is
referred to as the clustering effect and potentially impacts on the design and analysis adopted and thereby the
required sample size. The aim of this work was to inform trial design by quantifying clustering effects (at both
centre and surgeon level) for various outcomes using a database of surgical trials.
Methods: Intracluster correlation coefficients (ICCs) were calculated for outcomes from a set of 10 multicentre
surgical trials for a range of outcomes and different time points for clustering at both the centre and surgeon level.
Results: ICCs were calculated for 198 outcomes across the 10 trials at both centre and surgeon cluster levels. The
number of cases varied from 138 to 1370 across the trials. The median (range) average cluster size was 32 (9 to 51)
and 6 (3 to 30) for centre and surgeon levels respectively. ICC estimates varied substantially between outcome
type though uncertainty around individual ICC estimates was substantial, which was reflected in generally wide
confidence intervals.
Conclusions: This database of surgical trials provides trialists with valuable information on how to design surgical
trials. Our data suggests clustering of outcome is more of an issue than has been previously acknowledged. We
anticipate that over time the addition of ICCs from further surgical trial datasets to our database will further inform
the design of surgical trials.
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Background
Patients under the care of the same surgeon will be
influenced in a similar manner due to the surgeon’s
practice, skill and experience [1]. Outcomes for those
treated by the same surgeon tend to be more similar
than those under the care of another surgeon due to
previous experience, individual practice, training, and
infrastructure [2]. This phenomenon is referred to as
the clustering effect. While the impact of clustering of
outcome has been widely acknowledged for cluster ran-
domised controlled (C-RCTs) trials for some time
[1,3,4], its potential impact upon individually
randomised controlled trials (RCTs) evaluating therapist
dependent interventions, such as surgical interventions,
has only been highlighted more recently [1,5]. Models
which allow for clustering have been used to analyse
surgical trials though this is not commonly done [2,6-8].
Clustering has implications for the required sample
size of a RCT; the impact depends upon the design and
analysis adopted. For example, a RCT comparing two
surgical interventions which adopts an expertise-based
trial design, where each participating surgeon delivers
only one of the two surgical interventions under evalua-
tion, clustering is incorporated into the design at the
surgeon-level in a similar manner to a C-RCT [9]. Surgi-
cal versus medical trials (e.g. laparoscopic surgery versus
medical management [10]) have naturally been con-
ducted using an expertise-based design where relevant
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health professional only deliver one or the other of the
interventions [11]. Such a design, other factors being
equal, potentially leads to a relative loss of precision and
increase in the required sample size. In contrast, the
adoption of a stratified within-surgeon design can lead
to a reduction in the sample size [12]. A further trial
design option is a hybrid of these two approaches, such
as a surgeon preference trial, where each participating
surgeon opts to deliver either one of the two interven-
tions or both. A variety of statistical methods which
allow for clustering are available including both fixed
and random effects approaches [13].
Recruitment of participants to a RCT across multiple
centres (multicentre RCT) is commonly adopted to
increase both generalisability and the rate of recruit-
ment. Similar reasons, even if only implicitly recognised,
lead to the participation of multiple surgeons within and
across centres. Clustering in multicentre surgical trials,
as with other therapist dependent trials, could in princi-
ple, address clustering at the centre and/or surgeon
(therapist) level. A design consideration is whether ran-
domisation and the analysis should account for cluster-
ing at the centre and/or surgeon in a multi-centre
surgical RCT.
The statistical measure of the clustering between par-
ticipants under the care of a surgeon or centre is known
as the intracluster correlation coefficient [14], or ICC.
The ICC can be defined as the proportion of the total
variation in the participant outcome that can be attribu-
ted to the difference between clusters (e.g. surgeon) and
is often represented by r. The magnitude of clustering
could be influenced by a number of factors such as clus-
ter type (e.g. centre), setting and type of outcome and
the time since receiving the intervention [15].
Where a clustering effect exists, this has direct impli-
cations for the sample size calculations and the statisti-
cal analysis that is required. Standard sample size
calculations and analysis techniques assume that the
outcome for individual participants will be independent
and consequently they will incorrectly estimate (typically
underestimate) the true sample size required to detect a
pre-specified difference with the desired precision and
power. Correspondingly, statistical analyses which ignore
the presence of clustering will likely result in overly pre-
cise, and potentially misleading, results. Whereas the
impact is typically of an inflation in the sample size in
the case of C-RCTs, for individually randomised trials
the required sample size may be reduced [12].
Trialists have little data upon which to assess the
impact of clustering and appropriately modify trial
design. Quantifying the clustering effect would aid the
design of surgical trials [4]. There is, however, little
information available on the likely magnitude of ICCs in
surgical trials and it is very rare for surgical trials to use
such estimates during the design stage though there is a
growing awareness of the need to do so [7,9]. The aim
of this work was to inform trial design by quantifying
clustering effects (at both centre and surgeon level) for
various outcomes using a database of surgical trials.
Methods
ICCs were calculated for outcomes from a set of 10
multicentre surgical trials for a range of outcomes and
different time points (where applicable). Clustering was
assessed at both the centre and surgeon level indepen-
dently of each other. Trials recruited participants from
centres across the UK and Ireland, Germany or Europe.
Interventions under evaluation included general
(abdominal, endocrine, pancreatic and upper gastroin-
testinal), ophthalmology and orthopaedic (hip and knee)
surgical specialties. Of the 10 trials, five each included
centre and surgeon respectively in the randomisation
algorithm. One study [10] which evaluated a surgical
versus medical comparison had an expertise-based trial
design. Trials varied in size from 138 to 1370 partici-
pants; the median (range) number of centres and sur-
geon were 19 (8, 27) and 49 (16, 191) respectively.
Outcomes evaluated included perioperative (e.g. opera-
tion time), surgical (e.g. length of stay and recurrence of
hernia), functional (e.g. visual function) and both overall
(e.g. EQ-5D and SF-36) and disease-specific (e.g. Oxford
knee score) measures. The length of follow-up available
varied from short-term (six months or less) to long-
term (five years).
The ANOVA method was used to estimate an out-
come’s ICC along with bootstrapped 95% confidence
intervals (CI)[16,17]; this was done separately for each
trial. Two ANOVA models were used for every outcome;
one where centre and one where surgeon was the cluster-
ing factor. These analyses were carried out in Stata 11.1
utilising in combination the bootstrap and loneway com-
mands [18]. The bootstrap process allowed for the clus-
tered nature of the data and 1000 replications were
sampled. Both Bias Corrected (BC) and Bias Corrected
and Accelerated (BCA) 95% Bootstrapped CIs were cal-
culated for each outcome. If these bootstrapped CIs were
not calculable, a CI based upon the percentile bootstrap
method was used for the ICC. The operating surgeon
was used to define the cluster if surgeon was not
included in the randomisation algorithm. Post-interven-
tion data from the surgical interventions arms were used
to calculated the ICCs without adjustment for treatment.
Clustering information (cluster size distribution and out-
come prevalence/mean) were generated [19].
The design effect (or variance inflation factor) is the
value which the standard sample size needs to be multi-
plied by to account for the impact of clustering. For a
continuous outcome the impact upon a stratified
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within-surgeon design has been shown to be 1-r reflect-
ing a potential reduction in sample size over a standard
analysis [12]. Under an expertise-based trial, the formula
1+(average cluster size-1)*r can be used reflecting the
need to inflate the size to compensate for loss of infor-
mation. To illustrate the possible impact of adopting an
expertise-based trial design or stratified (or minimised)
within-surgeon design using the data from the 10 trials
to present plausible scenarios for two common out-
comes - one surgical (operation time) and one patient-
reported (EQ-5D at 12 months). In addition to the
actual cluster sizes, an adjusted cluster size using the
formula (∑ni
2)/∑ni) was also used which allows for the
impact of the variation in cluster size to be taken into
account [20].
Exploration of the relative contribution of the three
levels (1. participant, 2. surgeon and 3. centre) to the
overall variance was carried out using a three level
model (xtmixed command in Stata) for the EQ-5D at 12
months. The three corresponding ICCs (Level 2 ICC,
Level 3 ICC and Levels 2 and 3 ICC) for this model
were calculated along with BCA 95% CIs.
Results
Details of the 10 trials and information on the cluster
sizes are reported in Table 1. The median (range) aver-
age cluster size was 32 (9 to 51) and 6 (3 to 30) for cen-
tre and surgeon levels respectively. Surgeon cluster size
was smaller than centre size as expected for surgeons
nested within centres.
ICCs were calculated for 198 difference outcomes
across the 10 trials at both centre and surgeon cluster
levels. For 21 outcomes it was not possible to calculate
bias corrected bootstrapped CIs at centre and/or sur-
geon level and a CI based upon the bootstrap percentile
method was used instead. ICC estimates and corre-
sponding CIs of 48 outcomes (selected based upon pri-
mary outcomes of the included trials and other
commonly reported outcomes in the surgical literature)
are given in Table 2. Full details are available online at
http://www.abdn.ac.uk/hsru/research/research-tools/
study-design.
ICC estimates varied substantially between outcome
type, though uncertainty around individual ICC esti-
mates was substantial; this is reflected in generally wide
confidence intervals. A summary of the ICC estimates
by outcome is given in Table 3. Follow-up may also
impact upon the ICC estimate as the largest values
occurred when the outcome was measured closer in
time to the intervention (Table 3). Most CIs were con-
sistent with small or no clustering effect. There was evi-
dence of a substantial clustering effect for some
outcomes (e.g. operation time and length of stay). For
others, there appeared to be little or no clustering (e.g.
EQ-5D). ICC estimates appeared to be generally similar
for surgeon and centre level clustering.
Plausible impact on sample size under an expertise-
based design and stratified within-surgeon design are
shown in Table 4 for EQ-5D (12 months or longer) and
operation time. For EQ-5D adoption of a stratified
within-surgeon design protected against loss of informa-
tion while the impact of an expertise-based trial design
was dependent upon the anticipated cluster size if small
(e.g. less than 10) the inflation of sample size was under
10%. However for large cluster sizes, as occurred in
some of the trials, substantial increases in the required
samples could be anticipated. For operation time, the
large estimate ICC leads to large design effects even for
very small average cluster size. Large design effects were
plausible for an expertise-based trial design.
The results of the three level multilevel model are
shown in Table 5. The variance at the surgeon and cen-
tre levels appeared to be similar though the contribution
of the surgeon level was slightly higher though there
was a large amount of uncertainty regarding the relative
proportioning of variance between these two levels.
There was evidence of clustering when the variance of
levels 2 and 3 were considered together.
Table 1 Surgical trial datasets
Trial Surgical intervention(s) N No. Outcomes No. Surgeon No. Centres
CLIVIT [26] Thyroid surgery with clips or ligatures 491 5 125 13
DISPACT [27] Distal pancreatectomy with stapler or hand-sewn closure 352 6 126 21
FILMS [28] Macular hole surgery with/without peeling of Intra-limiting membrane. 138 19 N/A 9
HERNIA [29] Open vs. laparoscopic Inguinal hernia repair 928 41 31 24
INSECT [30] Midline laparotomy with one of three closure methods 625 6 191 24
KATMETAL [6] Total knee arthroplasty with/without metal backed tibial component 409 26 16 8
KATMOBILE [6] Total knee arthroplasty with/without mobile bearing between tibial
and femoral components
539 26 24 13
KATPATELLA [6] Total knee arthroplasty with/without patella resurfacing 1370 26 99 27
RELFUX [10] Laparoscopic fundoplication 178 20 31 19
STARS [31] Reduction and fixation, bipolar hemiarthroplasty or total hip arthroplasty 298 23 49 11
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Outcome Trial N Mean/
Prop
ICC BC 95% CI BCA 95% CI N Mean/
Prop
ICC BC 95% CI BCA 95% CI
EQ-5D 1 wk HERNIA 610 0.71 0.029 (0.003, 0.086) (0.004, 0.086) 610 0.71 0.023 (0.003, 0.057) (0.004, 0.070)
EQ-5D 3 m HERNIA 497 0.86 0 (0.000, 0.000)
*
(., .) 497 0.86 0 (0.000, 0.000)
*
(., .)
EQ-5D 3 m KATMETAL 361 0.66 0 (0.000, 0.000)
*
(., .) 361 0.66 0.014 (0.000, 0.104) (0.000, 0.119)
EQ-5D 3 m KATMOBILE 448 0.66 0.06 (0.005, 0.133) (0.007, 0.140) 448 0.66 0.071 (0.021, 0.149) (0.023, 0.159)
EQ-5D 3 m KATPATELLA 1169 0.70 0.008 (0.000, 0.041) (0.000, 0.047) 1169 0.70 0.005 (0.000, 0.032) (0.000, 0.032)
EQ-5D 3 m REFLUX 149 0.79 0.001 (0.000, 0.120) (0.000, 0.105) 104 0.82 0.001 (0.000, 0.120) (0.000, 0.105)
EQ-5D 4 m STARS 277 0.61 0 (0.000, 0.043) (0.000, 0.043) 277 0.61 0.015 (0.000, 0.109) (0.000, 0.112)
EQ-5D 12 m KATMETAL 354 0.71 0.006 (0.000, 0.070) (0.000, 0.070) 354 0.71 0 (0.000, 0.025) (0.000, 0.022)
EQ-5D 12 m KATMOBILE 448 0.70 0.040 (0.004, 0.103) (0.006, 0.107) 448 0.70 0.024 (0.000, 0.080) (0.000, 0.094)
EQ-5D 12 m KATPATELLA 1157 0.74 0.017 (0.000, 0.052) (0.000, 0.061) 1157 0.74 0.040 (0.011, 0.076) (0.013, 0.081)
EQ-5D 12 m REFLUX 152 0.75 0.007 (0.000, 0.107) (0.000, 0.100) 100 0.78 0.002 (0.000, 0.322) (0.000, 0.285)
EQ-5D 12 m STARS 274 0.63 0 (0.000, 0.063) (., .) 274 0.63 0 (0.000, 0.083) (., .)
EQ-5D 60 m KATMETAL 302 0.68 0 (0.000, 0.000)
*
(., .) 302 0.68 0 (0.000, 0.000)
*
(., .)
EQ-5D 60 m KATMOBILE 381 0.69 0.015 (0.000, 0.080) (0.000, 0.089) 381 0.69 0.019 (0.000, 0.065) (0.000, 0.076)
EQ-5D 60 m KATPATELLA 997 0.71 0.002 (0.000, 0.021) (0.000, 0.022) 997 0.71 0.009 (0.000, 0.047) (0.000, 0.050)
Oxford knee score 3 m KATMETAL 327 30.14 0 (0.000, 0.000)
*
(., .) 327 30.14 0.007 (0.000, 0.057) (0.000, 0.059)
Oxford knee score 3 m KATMOBILE 389 29.88 0.073 (0.016, 0.158) (0.020, 0.165) 389 29.88 0.068 (0.018, 0.130) (0.024, 0.142)
Oxford knee score 3 m KATPATELLA 1057 30.89 0.041 (0.014, 0.087) (0.016, 0.092) 1057 30.89 0.05 (0.021, 0.087) (0.021, 0.087)
Oxford knee score 12 m KATMETAL 311 33.71 0.021 (0.000, 0.042) (0.000, 0.042) 311 33.71 0.056 (0.000, 0.130) (0.001, 0.148)
Oxford knee score 12 m KATMOBILE 387 32.99 0.063 (0.023, 0.134) (0.026, 0.144) 387 32.99 0.059 (0.012, 0.134) (0.014, 0.139)
Oxford knee score 12 m KATPATELLA 1010 34.73 0.027 (0.004, 0.071) (0.005, 0.076) 1010 34.73 0.047 (0.015, 0.094) (0.016, 0.101)
Oxford knee score 60 m KATMETAL 284 34.14 0 (0.000, 0.000)
*
(., .) 284 34.14 0.002 (0.000, 0.021) (0.000, 0.021)
Oxford knee score 60 m KATMOBILE 350 33.43 0.044 (0.000, 0.123) (0.000, 0.160) 350 33.43 0.051 (0.000, 0.121) (0.004, 0.143)
Oxford knee score 60 m KATPATELLA 928 34.90 0.045 (0.016, 0.086) (0.017, 0.090) 928 34.90 0.037 (0.003, 0.074) (0.005, 0.077)
Operating time (min) CLIVIT 483 118.60 0.184 (0.084, 0.373) (0.069, 0.333) 479 118.93 0.392 (0.244, 0.524) (0.257, 0.528)
Operating time (min) DISPACT 344 190.03 0.268 (0.188, 0.418) (0.188, 0.418) 344 190.03 0.395 (0.254, 0.506) (0.259, 0.508)
Operating time (min) FILMS 125 67.55 0.212 (0.009, 0.451) (0.049, 0.486) NA
Closure time (min) INSECT 580 15.02 0.331 (0.129, 0.587) (0.149, 0.661) 579 15.03 0.466 (0.338, 0.593) (0.342, 0.600)
Operating time (min) KATMETAL 398 106.70 0.449 (0.172, 0.726) (0.183, 0.731) 398 106.70 0.514 (0.278, 0.727) (0.302, 0.752)
Operating time (min) KATMOBILE 503 122.37 0.167 (0.092, 0.294) (0.093, 0.295) 503 122.37 0.199 (0.073, 0.390) (0.073, 0.390)
Operating time (min) KATPATELLA 1302 126.75 0.370 (0.254, 0.470) (0.259, 0.478) 1302 126.75 0.445 (0.360, 0.524) (0.369, 0.533)
Operating time (min) REFLUX 108 112.81 0.375 (0.066, 0.623) (0.060, 0.623) 104 113.16 0.375 (0.066, 0.623) (0.060, 0.623)
Operating time (min) STARS 298 62.40 0.072 (0.021, 0.278) (0.022, 0.278) 298 62.40 0.093 (0.003, 0.222) (0.013, 0.248)
Length of stay (days) CLIVIT 488 3.05 0.065 (0.000, 0.367) (0.000, 0.319) 485 3.05 0 (0.000, 0.397) (0.000, 0.345)
Length of stay (days) DISPACT 348 15.41 0.111 (0.012, 0.217) (0.005, 0.210) 348 15.41 0.045 (0.000, 0.307) (0.000, 0.266)
Length of stay (days) INSECT 589 14.59 0.012 (0.000, 0.059) (0.000, 0.049) 588 14.59 0 (0.000, 0.525) (0.000, 0.421)
Length of stay (days) REFLUX 108 2.38 0.345 (0.128, 0.590) (0.146, 0.601) 104 2.38 0.345 (0.128, 0.590) (0.146, 0.601)
Length of stay (days) STARS 298 12.26 0.104 (0.002, 0.354) (0.014, 0.420) 298 12.26 0.104 (0.002, 0.354) (0.014, 0.420)
Fistula DISPACT 352 0.29 0.122 (0.046, 0.301) (0.039, 0.284) 352 0.29 0.084 (0.000, 0.220) (0.000, 0.236)
Complication 6 m FILMS 126 0.38 0 (0.000, 0.000)
*
(., .) NA
Complication 1 wk HERNIA 717 0.37 0 (0.000, 0.017) (., .) 717 0.37 0.009 (0.000, 0.050) (0.000, 0.053)
Wound infection INSECT 625 0.16 0.01 (0.000, 0.037) (0.000, 0.043) 610 0.16 0.072 (0.000, 0.183) (0.000, 0.186)
HRQ overall score 4 m STARS 276 68.85 0.058 (0.020, 0.207) (0.019, 0.207) 276 68.85 0.114 (0.030, 0.222) (0.032, 0.224)
HRQ overall score 12 m STARS 258 74.04 0 (0.000, 0.093) (0.000, 0.062) 258 74.04 0 (0.000, 0.126) (., .)
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Discussion
Our data on clustering effect for multicentre trials of
surgical interventions suggests it is more of an issue
than has been previously acknowledged. Despite the
uncertainty intrinsic to estimating the magnitude of the
ICC, there was evidence of clustering effect for a num-
ber of outcomes. As the outcomes with the highest ICC
estimates (e.g. operation time and length of stay) are
typically cost rather than clinical outcomes, clustering is
likely to have the greatest impact on the economic eva-
luation. This database provides trialists with valuable
information on how to design surgical trials. In particu-
lar it supports the wisdom of including either centre or
surgeon (if a within-surgeon design is used) in the ran-
domisation algorithm. The failure to analyse accordingly
can result in a loss of precision [7,12].
The individual ICC estimates were suggestive of clus-
tering for a number of outcomes. The ICC estimates for
centre and surgeon level did not markedly differ as
might be anticipated given that surgeons are typically
nested within a centre. It is likely that the observed clus-
tering by surgeon is driven by a number of factors and
not just the surgeon per se. Furthermore where surgeon
is used in the randomisation algorithm in practice this
may function as a sub-centre (e.g. surgeons in the same
surgical team) as opposed to reflecting an individual
surgeon and hence can be in between centre and pure
surgeon grouping. The latter is often more difficult to
achieve than might be initially expected, particularly in a
routine health care setting, as surgical trainees often
undertake elements of the whole operation under the
supervision of a senior surgeon or more senior surgeons
work in a team environment.
The difficulties in estimating the uncertainty around a
ICC estimate are well known [21]. We used the
ANOVA method (along with bootstrapped confidence
intervals) as it has been shown not to require any strict
distributional assumptions and can be used for both
continuous and binary outcomes [22]. Following other
authors, we consider a negative ICC implausible; the
ICC estimates were censored at zero [17,22]. Where the
ICC estimate was close to zero, the reported ICC confi-
dence interval limits may be slightly inflated as a conse-
quence [15,17]. As surgical trial datasets do not tend to
be large enough for precise estimate of ICC, the utiliza-
tion of routinely collected data, perhaps in conjunction
with surgical trial datasets, could be considered. Formal
meta-analysis of ICC estimates would in principle pro-
vide the optimal use of available data and achieve
greater precision [23]. Furthermore, ICC estimates can
be calculated with adjustment for other important fac-
tors (e.g. baseline values for quality of life measures)
which are likely to reduce the ICC estimates. Our esti-
mates are unadjusted and therefore may be an overesti-
mate of clustering provided the statistical analysis
adjusts for such factors. The exploratory three level ana-
lysis suggested variance might be contributed from both
the surgeon and centre levels as might be considered
Table 2 Individual ICC estimates at centre and surgeon levels (Continued)
HRQ overall score 24 m STARS 236 75.37 0 (0.000, 0.000)
*
(., .) 236 75.37 0 (0.000, 0.167) (., .)
RQLS score 3 m REFLUX 141 83.85 0.143 (0.000, 0.392) (0.009, 0.449) 100 86.34 0.143 (0.000, 0.392) (0.009, 0.449)
RQLS score 12 m REFLUX 145 84.58 0.058 (0.000, 0.229) (0.000, 0.240) 94 89.10 0 (0.000, 0.263) (., .)
Distance visual acuity
(ETDRS) 6 m
FILMS 127 60.24 0.175 (0.004, 0.327) (0.013, 0.344) NA
BC 95% CI: Bias corrected bootstrapped 95% confidence interval; BCA 95% CI: Bias corrected and accelerated bootstrapped 95% confidence interval; ETDRS: Early
Treatment Diabetic Retinopathy Study; EQ-5D: EUROQOL 5D-3L; HRQ: Hip replacement questionnaire; ICC: Intracluster correlation coefficient; m: month; min:
minutes; NA: not applicable; Prop: proportion; RQLS: REFLUX quality of life measure; wk: week.
* 95% bootstrapped confidence interval using percentile method.
Table 3 Summary of ICC estimates
Centre level Surgeon level
Outcome N Med Min Max N Med Min Max
EQ-5D 1 wk 1 0.029 - - 1 0.023 - -
EQ-5D 3 m 6 0.001 0 0.06 6 0.015 0 0.071
EQ-5D 12 m 5 0.007 0 0.04 5 0.002 0 0.04
EQ-5D 60 m 3 0.002 0 0.02 3 0.009 0 0.019
Oxford knee score 3 m 3 0.041 0 0.07 3 0.05 0.007 0.068
Oxford knee score 12 m 3 0.027 0.021 0.06 3 0.056 0.047 0.059
Oxford knee score 60 m 3 0.044 0 0.05 3 0.037 0.002 0.051
Operating time 9 0.268 0.072 0.45 8 0.394 0.093 0.514
Length of stay 5 0.104 0.012 0.35 5 0.045 0 0.345
Surgical complications* 4 0.005 0 0.12 4 0.072 0.009 0.084
HRQ overall score 4 m 1 0.058 - - 1 0.114 - -
HRQ overall score 12 m 1 0 - - 1 0 - -
HRQ overall score 24 m 1 0 - - 1 0 - -
RQLS score 3 m 1 0.143 - - 1 0.143 - -
RQLS score 12 m 1 0.058 - - 1 0 - -
Dist. visual acuity
(ETDRS) 6 m
1 0.175 - - - - - -
Dist.: distance; EQ-5D: EUROQOL 5D-3L; ETDRS: Early Treatment Diabetic
Retinopathy Study; HRQ: Hip replacement Questionnaire; ICC: Intracluster
correlation coefficient; N: number of observations; m: month; Max: Maximum;
Med: median; Min: minimum; RQLS: REFLUX quality of life measure; wk: week.
* Surgical complication group contains a variety of definition of complications
and variable follow-up time periods.
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intuitively the case. However, even for the largest dataset
in the database the uncertainty around the estimates
was substantial.
Expertise-based trials have been used and promoted as
a preferable design to the standard within-surgeon (stra-
tified) design. Purported benefits of this design include
increased surgical participation and compliance with
randomisation, addressing the learning curve effect
along with desirability from a patient perspective. How-
ever, expertise-based designs have been criticized on a
number of grounds [24] including methodological con-
siderations and particularly the required sample size.
The data presented provides clarification on the poten-
tial impact which would appear to be related to the out-
come(s) of interest. Expertise-based design, perhaps
contrary to intuition, seems a (statistically) suboptimal
choice for a comparison of surgical interventions where
surgical outcomes (e.g. operation time, short recovery)
are of interest. Of the trials included in the database,
four focussed upon surgical primary outcomes. A better
option would be surgeons with expertise in both surgical
interventions delivering both interventions. In contrast
an expertise-based trials seems a reasonable choice if
long-term quality of life was the primary focus of the
study as small, perhaps even zero, clustering was plausi-
ble for such outcomes. A caveat may be appropriate
where stratification by centre was undertaken (and ana-
lysed accordingly) despite surgeons only delivering one
or the other of the interventions. The impact of such an
approach is unclear and empirical evaluation of statisti-
cal analysis options of an expertise-based trial is needed
to evaluate the impact upon required sample size.
Where the clustering is anticipated to be small e.g. a
longer term quality of life outcome, the potential
recruitments benefits (particular of surgeons) of an
expertise-based design could be seen as a reasonable off-
set to the loss of precision and need to recruit slightly
more participants. It has been suggest that the effect
size under an expertise-based design might be larger
though there is little evidence to support such a premise
at present. A hybrid [9] (or more specifically, surgeon
preference) design, where surgeons are allowed to per-
form either one or both surgical interventions in a com-
parison of two surgical interventions, might therefore be
the optimal design where the two surgical interventions
Table 4 Possible design effect for a continuous outcome based upon database
Outcome ICC† Average cluster size Design effectc
expertise-based design stratified design
EQ-5D 12 m 0.01 min(centre)* 9.4 1.08 0.99
0.01 median(centre)* 32.4 1.31 0.99
0.01 max(centre)* 51.1 1.50 0.99
0.01 median adj.(centre)‡ 64.4 1.63 0.99
0.01 min(surgeon)* 2.8 1.02 0.99
0.01 median(surgeon)* 6.1 1.05 0.99
0.01 max(surgeon)* 29.9 1.29 0.99
0.01 median adj.(surgeon)‡ 35.3 1.34 0.99
Operation time 0.27 min(centre)* 9.4 3.27 0.73
0.27 median(centre)* 32.4 9.48 0.73
0.27 max(centre)* 51.1 14.53 0.73
0.27 median adj.(centre)‡ 64.4 18.12 0.73
0.27 min(surgeon)* 2.8 1.49 0.73
0.27 median(surgeon)* 6.1 2.38 0.73
0.27 max(surgeon)* 29.9 8.80 0.73
0.27 median adj.(surgeon)‡ 35.3 10.25 0.73
ICC: Intracluster correlation coefficient.
† ICC was based upon median of observed values.
* Average cluster size based upon actual cluster sizes across trials in the database.
‡ Average cluster size calculated using the formula (∑ni
2)/∑ni) where ni is the number of observations in the i
th cluster.
c Design effect was calculated using 1+(average cluster size-1)*r and 1-r for expertise-based trial and stratified design respectively.
Table 5 Three level multilevel model (patient within
surgeon within centre)
Outcome ICC Estimate† 95% CI*
EQ-5D 12
m
Level 2 (surgeon) 0.417 (0.000, 0.857)
Level 3 (centre) 0.012 (0.000, 0.003)
Levels 2 (surgeon) and 3
(centre)
0.029 (0.005, 0.053)
CI: confidence interval; EQ-5D: EUROQOL 5D-3L; ICC: Intracluster correlation
coefficient.
multilevel model using xtmixed command in Stata with no adjustment for
treatment or other factors.
* 95% bootstrapped (bias corrected and accelerated) confidence interval
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substantially differ and the focus is on longer term qual-
ity of life outcomes.
Typically the statistical analysis of RCTs which allow
for clustering across multicentre or therapists enable the
underlying intercept level to vary between cluster but
maintains a common treatment effect. Methods which
allow for the treatment effect to vary between cluster in
place of or in addition to underlying level has been pro-
posed [25]. The relative impact of such options is
unclear and further evaluation, specifically regarding the
impact on sample size, is needed.
Differential clustering or clustering for only one inter-
vention may be plausible. The method of analysis we
undertook implicitly assumed a common ICC across the
surgical interventions. For some of the settings repre-
sented by the surgical trials in our database (e.g. total
knee arthroplasty with/without metal backed tibial com-
ponent) a common ICC is very plausible where as for
others (open versus laparoscopic hernia repair) this is
perhaps less so. Due to the relatively small number of
cases (as reflected in some CIs not being calculable) we
choose to only calculate the common ICC across the
interventions. This might be viewed as the most appro-
priate approach in the presence of any treatment effect.
There is a need for ICC estimates and providing data
on cluster sizes to be routinely published [4,15]. This
database of surgical ICC provides information to guide
trialists in the design of trials evaluating surgical inter-
ventions as has been done for other areas [15]. Further
research is needed into ICC estimates, both in their
determinants and the optimal method of calculation
(including consideration of meta-analysis). We anticipate
that over time the addition of ICCs from further surgical
trial datasets to our database will further inform the
design of surgical trials; trialists are invited to submit
surgical trial ICCs for inclusion in the database.
Conclusions
Sizeable clustering effects in multicentre trials of surgi-
cal interventions at both centre and surgeon levels were
plausible for some outcomes. A stratified design (by
either centre or surgeon) with corresponding analysis
provides optimal benefit with regard to sample size and
protects against a potentially large loss of precision for
surgical outcomes. Further research is needed into sur-
gical ICCs, into both their determinants and the optimal
method of calculation.
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